Moreover, this topic has been analyzed in a previous meta-analysis, that demonstrated an increased breast cancer risk in BRCA1/2 mutation carriers for individuals with both alleles C29 polyglutamine repeat [30]. The gene discussed is BRCA1; the disease is breast cancer.